机译:基于药效学评估的开腹手术炎症性肠病患者的头孢吡肟的腹膜药代动力学和剂量考虑因素
Department of Clinical Pharmacotherapy Graduate School of Biomedical Sciences Hiroshima University 1-2-3 Kasumi Minamiku Hiroshima 734-8551 Japan;
Department of Clinical Pharmacotherapy Graduate School of Biomedical Sciences Hiroshima University 1-2-3 Kasumi Minamiku Hiroshima 734-8551 Japan;
Department of Clinical Pharmacotherapy Graduate School of Biomedical Sciences Hiroshima University 1-2-3 Kasumi Minamiku Hiroshima 734-8551 Japan;
Department of Surgery Graduate School of Biomedical Sciences Hiroshima University Hiroshima Japan;
Department of Surgery Graduate School of Biomedical Sciences Hiroshima University Hiroshima Japan;
Department of Pharmacy Kagawa University Hospital Kagawa Japan;
Department of Clinical Pharmacotherapy Graduate School of Biomedical Sciences Hiroshima University 1-2-3 Kasumi Minamiku Hiroshima 734-8551 Japan;
Cefepime; Peritoneal fluid; Pharmacokinetics; Pharmacodynamics;
机译:头孢吡肟在炎症性肠病剖腹患者中的腹膜药代动力学,以及基于药效学评估的外科腹腔内感染的剂量注意事项。
机译:临床药代动力学和药效学考虑炎症性肠病疾病的治疗方法
机译:根据药代动力学/药效学(PK / PD)评估加替沙星治疗老年患者呼吸道感染的临床剂量。
机译:模拟炎症性肠病的细菌和病毒感染
机译:炎症性肠病的间隔期大剂量维生素D治疗
机译:头孢吡肟美洛培南和哌拉西林-他唑巴坦使用药代动力学/基于药效学的剂量计算器在重症患者中的药效学目标达成
机译:哌啶蓟素 - 唑唑米在血浆,腹膜液和腹膜腹膜腹膜腹膜腹膜内的药代动力学,以及基于现场特异性药学目标达到的给药考虑因素